Seniors' uncertainty management of direct-to-consumer prescription drug advertising usefulness

Health Communication

Volumn 24, Issue 6, 2009, Pages 494-503

  DeLorme, Denise E ^a   Huh, Jisu ^b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERTIZING; AGED; ARTICLE; CONSUMER; FEMALE; HUMAN; INTERVIEW; MALE; UNCERTAINTY; UNITED STATES;

ADVERTISING AS TOPIC; AGED; CONSUMER PARTICIPATION; FEMALE; FLORIDA; HUMANS; INTERVIEWS AS TOPIC; MALE; PHARMACEUTICAL PREPARATIONS; UNCERTAINTY;

EID: 70349606400     PISSN: 10410236     EISSN: None     Source Type: Journal    
DOI: 10.1080/10410230903104277     Document Type: Article

References (63)

1. AARP. (2001). The policy book: AARP public policies. Washington, DC: Author.
2. AdWeek Online. (2005, October 27). DTC drug ads come under fire. AdWeek Online. Available at: http://www.adweek.com/aw/national/article_display.jsp?vnu_content_id=1001391081
3. Allison-Ottey, S. D., Ruffin, K., & Allison, K. B. (2002). To do no harm: Survey of NMA physicians regarding perceptions on DTC advertisements. Journal of the National Medical Association, 94, 194-202.
4. Auton, F. (2004). The advertising of pharmaceuticals direct to consumers: A critical review of the literature and debate. International Journal of Advertising, 23, 5-52.
5. Babrow, A. S., & Mattson, M. (2003). Theorizing about health communication. In T. L. Thompson, A. M. Dorsey, K. I. Miller, & R. Parrott (Eds.), Handbook of health communication (pp. 35-61). Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
6. Balazs, A. L. (2004). Marketing to older adults. In J. F. Nussbaum & J. Coupland (Eds.), Handbook of communication and aging research (pp. 329-351). Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
7. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651-657.
8. Berg, B. L. (2007). Qualitative research methods for the social sciences (5th ed.). Boston: Allyn & Bacon/Pearson Education.
9. Blue Cross Blue Shield Association. (2002, March 7). Business leaders identify healthcare cost drivers: BCBSA research highlights perception of key cost drivers [Press release]. Chicago, IL: Author.
10. Brashers, D. E. (2001). Communication and uncertainty management. Journal of Communication, 51, 477-497.
11. Brashers, D. E. (2007). A theory of communication and uncertainty management. In B. Whaley & W. Samter (Eds.), Explaining communication (pp. 201-218). Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
12. Brashers, D. E., & Neidig, J. L. (2000). Communication in the management of uncertainty: The case of persons living with HIV or AIDS. Communication Monographs, 67, 63-84.
13. Brashers, D. E., Neidig, J. L., & Goldsmith, D. J. (2004). Social support and the management of uncertainty for people living with HIV or AIDS. Health Communication, 16, 305-331.
14. Brashers, D. E., Neidig, J. L., Haas, S. M., Dobbs, L. K., Cardillo, L. W., & Russell, J. A. (2000). Communication in the management of uncertainty: The case of persons living with HIV or AIDS. Communication Monographs, 67, 63-84.
15. Calfee, J. E. (2002). Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21, 174-193.
16. Calfee, J. E. & Ringold, D. J. (1994). The 70% majority: Enduring consumer beliefs about advertising. Journal of Public Policy & Marketing, 13, 228-239.
17. Chandra, A., & Holt, G. A. (1999). Pharmaceutical advertisements: How they deceive patients. Journal of Business Ethics, 18, 359-366
18. Cohen, D., McCubbin, M., Collin, J., & Perodeau, G. (2001). Medications as social phenomena. Health: An Interdisciplinary Journal for the Social Study of Health, Illness & Medicine, 5, 441-469.
19. Cohen, J. B. (2002). Introductory comments: Direct-to-consumer prescription drug advertising: Evaluating regulatory policy in the United States and New Zealand. Journal of Public Policy & Marketing, 21, 172-173.
20. Coney, S. (2002). Direct-to-consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. Journal of Public Policy & Marketing, 21, 213-223.
21. Datti, B., & Carter, M. W. (2006). The effect of direct-to-consumer advertising on prescription drug use by older adults. Drugs & Aging, 23, 71-81.
22. DeLorme, D., Huh, J., & Reid, L. N. (2006). Perceived effects of DTC prescription drug advertising on self and others: A third-person effect study of older consumers. Journal of Advertising, 35(3), 49-68.
23. Denzin, N. K. (1978). Sociological methods, New York: McGraw-Hill.
24. Findlay, S. D. (2001). Direct-to-consumer promotion of prescription drugs: Economic implications for patients, payers and providers. Pharmacoeconomics, 19, 109-119.
25. Food and Drug Administration. (1999a). Attitudes and behaviors associated with direct-to-consumer promotion of prescription drugs. Retrieved from http://www.fda.gov/cder/ddmac/research.htm
26. Food and Drug Administration. (1999b). Guidance for industry: Consumerdirected broadcast advertisements. Retrieved from http://www.fda.gov/cder/guidance/1804fnl.pdf
27. Food and Drug Administration. (2004a). Final report: Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs. Retrieved from http://www.fda.gov/cder/ddmac/researchka.htm
28. Food and Drug Administration. (2004b). Guidance for industry brief summary: Disclosing risk information in consumer-directed print advertisements draft guidance. Retrieved from http://www.fda.gov/cder/guidance/5669dft.pdf
29. Freudenheim, M. (2005, October 3). To promote a new drug benefit, marketers are using some old scripts. New York Times, pp. C1-C6.
30. Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. New York: Aldine De Gruyter.
31. Hoek, J., & Gendall, P. (2002). Direct-to-consumer advertising down under: An alternative perspective and regulatory framework. Journal of Public Policy & Marketing, 21, 202-212.
32. Hoek, J., Gendall, P., & Calfee, J. (2004). Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: An analysis of regulatory approaches and consumer responses. International Journal of Advertising, 23, 197-227.
33. Hollon, M. F. (1999). Direct-to-consumer marketing of prescription drugs: Creating consumer demand. The Journal of the American Medical Association, 281, 382
34. Huh, J., DeLorme, D. E., & Reid, L. N. (2004). The third-person effect and its influence on behavioral outcomes in a product advertising context: The case of direct-to-consumer prescription drug advertising. Communication Research, 31, 568-599.
35. Huh, J., DeLorme, D. E., & Reid, L. N. (2006). Perceived third-person effects and consumer attitudes on pre-vetting and banning DTC advertising. Journal of Consumer Affairs, 40, 90-116.
36. Jones, K. O., Denham, B. E., & Springston, J. K. (2007). Differing effects of mass and interpersonal communication on breast cancer risk estimates: An exploratory study of college students and their mothers. Health Communication, 21, 165-175.
37. Kaiser Family Foundation. (2005). Kaiser health poll report, January/February 2005, featured topic-Views on prescription drugs and the pharmaceutical industry. Retrieved from http://www.kff.org/healthpollreport/ feb_2005/index.cfm
38. Kopp, S. W., & Sheffet, M. J. (1997). The effect of direct-to-consumer advertising of prescription drugs on retail gross margins: Empirical evidence and public policy implications. Journal of Public Policy & Marketing, 16, 270-276.
39. Lazarus, R. S. (2001). Relational meaning and discrete emotions. In K. R. Scherer, A. Schorr & T. Johnstone (Eds.), Appraisal processes in emotion: Theory, methods, research, New York: Oxford University Press.
40. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
41. Lexchin, J., & Mintzes, B. (2002). Direct-to-consumer advertising of prescription drugs: The evidence says no. Journal of Public Policy & Marketing, 21, 194-201.
42. McCracken, G. (1988). The long interview. Newbury Park, CA: Sage.
43. Merry, U. (1995). Coping with uncertainty: Insights from the new sciences of chaos, self-organization, and complexity. Westport, CT: Praeger.
44. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: A sourcebook of new methods. Newbury Park, CA: Sage.
45. Mintzes, B. (2001). An assessment of the health system impacts of directto- consumer advertising of prescription medicines (DTCA). Volume II: Literature review direct-to-consumer advertising of prescription drugs: What do we know thus for about its effects on health and health care services? University of British Columbia, unpublished manuscript.
46. Montagne, M. (1992). Drug advertising and promotion: An introduction. Journal of Drug Issues, 22, 195-203.
47. Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2003). Direct-to-consumer advertising: Physicians' views of its effects on quality of care and the doctor-patient relationship. Journal of the American Board of Family Practice, 16, 513-524.
48. Nussbaum, J. F., Pecchioni, L. L., Robinson, J. D., & Thompson, T. L. (2000). Communication and aging (2nd ed.). Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
49. Palumbo, F., & Mullins, C. D. (2002). The development of direct-toconsumer prescription drug advertising regulation. Food and Law Journal, 57, 423.
50. Reisenwitz, T., & Wimbish, G. J. (1997). The purchase decision process and involvement of the elderly regarding non-prescription products. Health Marketing Quarterly, 15, 49-68.
51. Pfizer Inc. (2001). Prescription drug advertising: Empowering consumers through information. Economic Realities in Health Care Policy, 2(1). Available at: http://media.pfizer.com/files/policy/about_ERhealthcare.pdf
52. Robinson, A. R., Hohmann, K. B., Rifkin, J. I., Topp, D., Gilroy, C. M., Pickard, J. A., et al. (2004). Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine, 164, 427-432.
53. Rook, K. S., Charles, S. T., & Heckhausen, J. (2007). Aging and health. In H. S. Friedman & R. C. Silver (Eds.), Foundations of health psychology (pp. 234-262). Oxford, UK: Oxford University Press.
54. Rotfeld, H. J. (2003). Misplaced marketing: "It hurts. Fix it." The patients' lament and unhealthy medical care marketing. Journal of Consumer Marketing, 20, 7-9.
55. Schwartz, V. E., Silverman, C., Hulka, M. J., & Appel, C. E. (2009). Marketing pharmaceutical products in the twenty-first century: An analysis of the continued viability of traditional principles of law in the age of direct to consumer advertising. Harvard Journal of Law and Public Policy, 32(1), 333-362.
56. Shaw, M. (2001). The DTC dilemma. Pharmaceutical Executive, 21(5), 104-112.
57. Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures and techniques, Newbury Park, CA: Sage.
58. U.S. Census Bureau. (2007). Age and sex distribution in 2005. Retrieved from http://www.census.gov/population/pop-profile/dynamic/AgeSex.pdf
59. U.S. Government Accountability Office. (2006). Prescription drugs: Improvements needed in FDA's oversight of direct-to-consumer advertising: Report to congressional requesters. Washington, DC: Author. Available at: http://purl.access.gpo.gov/GPO/LPS78710.
60. Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110-128.
61. Williams, R. D. (1997). Medications and older adults. FDA Consumer, 31(6), 15-18.
62. Winter, G. (2005, December). Inside DDMAC. Pharmaceutical Executive, 25(12), 48-50.
63. Wolfe, S. M. (2002). Direct-to-consumer advertising-Education or emotion promotion? New England Journal of Medicine, 346, 523-528.